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Abstract
Background: Tuberculosis (TB) is one of the major public health problems in Zambia. However, information about 
lineages of M. tuberculosis complex (MTBC) isolates useful for epidemiology investigations is unknown. In this study, we 
investigated the diversity of MTBC isolates from Ndola, a typical Zambian urbanized city with a documented high HIV 
prevalence.
Methods: This was part of a prospective cohort study in subjects with sputum smear-positive pulmonary TB. 
Spoligotyping was used to genotype the MTBC isolates and establish the circulating lineages. The 15-locus 
Mycobacterial Interspersed Repetitive Units - Variable Number Tandem Repeats (MIRU-VNTR) typing was used to study 
recent transmission.
Results: A total of 98 different spoligotypes were identified among 273 MTBC isolates. The majority (64.8%) of the 
isolates belonged to 9 known families, while 96 (35.2%) of the isolates were orphans. While LAM (41.8%) was the largest 
spoligotype family observed, most of the isolates (87.7%) belonging to the SAF1 family, with a significant portion 
coming from the T (13.6%), and X (5.9%) families. A few isolates (3.6%) belonged to the CAS, EAI, H, S, X1-LAM9 or U 
families. MIRU-VNTR typing was highly discriminatory (h = 0.988) among the 156 isolates tested in our sample, and 
increased the discrimination among 82 SAF1 isolates from 6 to 46 distinct patterns. In addition, 3.2% (5/156) of cases 
with available MIRU-VNTR results harbored more than one MTBC strain.
Conclusions: Our findings show a limited diversity of MTBC in Ndola with a high clustering rate (37.7%), which 
indicates that recent transmission plays an appreciable role in the dynamics of TB disease in this setting. This 
conclusion emphasizes the importance of early diagnosis and timely treatment. The results also confirm that MIRU-
VNTR typing is suitable for studying the molecular epidemiology of TB in Ndola.
Background
Zambia is ranked among the world's top 10 high TB inci-
dence countries with an incidence rate of 280 smear-pos-
itive tuberculosis (TB) cases per 100,000 inhabitants [1].
The World Health Organization (WHO) estimates the
prevalence of all forms of TB in Zambia at 707/100,000
[1]. According to the National Tuberculosis Leprosy Pro-
gram (NTLP), in 2004, the Copperbelt Province was
responsible for nearly a third (27.6%) of the nation's noti-
fied TB cases. It was also one of the provinces with the
highest Human Immunodeficiency Virus (HIV) preva-
lence (17%) in Zambia [2]. While efforts have been made
to identify drivers of the HIV pandemic in Zambia, simi-
lar efforts for the TB epidemic lag far behind. A number
of surveillance activities, both biological and socio indica-
tor - studies, which are useful in identifying the risk fac-
tors that play a role in driving the HIV epidemic in
Zambia, have been implemented. However, efforts in TB
have mainly relied on generic recommendations to pre-
vent TB. The epidemiology of TB in Zambia still remains
largely unknown, and consequently, epidemiological data
cannot help focus TB control strategies. In high TB inci-
dence settings, determination of distinct transmission
patterns is often indefinable, but may be greatly enhanced
by the use of both molecular and conventional epidemio-
logical tools. * Correspondence: chandamulenga@yahoo.com
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Use of molecular markers for strain-specific differentia-
tion of Mycobacterium tuberculosis-complex (MTBC)
isolates in epidemiological studies became available in
the last decades. Some of the more popular MTBC typing
methods being used include IS6110-based restriction
fragment length polymorphism (RFLP) [3] and PCR-
based methods like spoligotyping [4], mycobacterial
interspersed repetitive units - variable number of tandem
repeats (MIRU-VNTR) [5-8], single-nucleotide polymor-
phisms [9,10] and large-sequence polymorphism analysis
[11-14]. Furthermore, apart from differentiating MTBC
strains, MIRU-VNTR typing can easily identify mixed
infections in patient isolates. Even so, the choice of typing
methods used in studies should be considered carefully to
provide meaningful analysis because their ability to dis-
criminate MTBC in different settings varies widely. In
addition, knowledge on the (over-) representation of spe-
cific genotype families in a community can be important,
especially if these families have been implicated in dis-
ease complications like drug resistance, severe disease, or
increased transmissibility.
In this study, we set out to investigate the circulating
MTBC isolates, and use spoligotyping and 15-locus
MIRU-VNTR typing to distinguish MTBC isolates from
Ndola, an urban city on the Copperbelt Province of Zam-
bia.
Methods
Study setting and population
This was part of a prospective cohort study in subjects
with sputum smear-positive pulmonary TB, conducted in
the Ndola urban district on the Copperbelt Province of
Zambia. The Ndola District Health Management Team
(DHMT) is responsible for health care service delivery in
the district and has a catchment population of about
374,750 persons [15]. The district has 21 health centres, 3
m i l i t a r y  c l i n i c s ,  a n d  2  t e r t i a r y  c a r e  h o s p i t a l s .  M o s t  o f
these health centres are able to deliver TB treatment and
care and are referred to as treatment centres, but only 6
are able to provide laboratory services for smear micros-
copy and are referred to as diagnostic centres.
For this study, sputum samples were collected from all
consecutive sputum smear-positive pulmonary TB sub-
jects at 4 of the 6 existing TB diagnostic centres between
January and July 2006 as per routine. Both previously-
untreated (new) and previously-treated (retreatment)
cases were enrolled. The two clinics not included in the
study were left out mainly because of their comparatively
low population catchment areas at the time and because
o f  l o g i s t i c a l  p r o b l e m s .  A l l  T B  p a t i e n t s  w e r e  t r e a t e d
according to the national TB guidelines [16] in line with
the WHO treatment guidelines [17]. Smear-negative sub-
jects were excluded because of logistical limitations such
as budgetary and manpower constraints.
Laboratory methods
After routine microscopy, sputum smear-positive sam-
ples were stored in cetylpyridinium chloride (CPC) trans-
port medium and kept at ambient temperature until they
were taken to the Tropical Diseases Research Centre
(TDRC) on a weekly basis. The samples were later trans-
ported from TDRC to the Chest Diseases Laboratory
(CDL), a reference laboratory in Lusaka, for culture on
Löwenstein-Jensen (LJ) medium following decontamina-
tion using the Petroff method [18]. Culture tubes were
incubated at 37°C and were read weekly for growth for at
least eight weeks. Successfully grown cultures were trans-
ported back to TDRC for storage and onward transporta-
tion of isolates to the Institute of Tropical Medicine
(ITM, Antwerp, Belgium) for further analysis.
Data collection methods
The clinics were provided with a register dedicated for
the study to record study-subject information, which
included socio-demographics (name, sex, age, residence)
and clinical data (case type, smear-microscopy results for
three time points during treatment treatment regimen
followed, and treatment outcome). HIV data could not be
collected at that time, because routine counseling and
testing (CT) for TB patients had not yet been imple-
mented by 2006, and it was not logistically possible to
capture this data in the study. As quality control, the
study register was checked against the clinic TB registers
at the end of the collection period.
DNA extraction
To obtain genomic DNA for spoligotyping and MIRU-
VNTR typing, mycobacterial colonies grown on LJ
medium were resuspended in 200 μl 1 × Tris EDTA buf-
fer (10 Mm Tris-HCl, 1 Mm Ethylenediaminetetracetic
acid disodium [pH8.0]) and then boiled for 10 min. The
suspension was centrifuged at 15 000 g for 1 min to pellet
cell debris. The supernatant containing DNA was har-
vested and used in PCR reactions.
DNA fingerprinting
Spoligotyping was performed using a commercial kit
(Isogen Bioscience B.V., Maarssen, The Netherlands)
according to Kamerbeek et al. [4]. Standardized MIRU-
VNTR typing based on 15 loci was performed using the
manual method [19] or by the automated method at
Genoscreen in Lille, France.
Investigation of laboratory cross contamination
The investigation of possible laboratory cross contamina-
tion or error was performed by reviewing the DNA-fin-
gerprint patterns of clustered isolates from samples that
were processed on the same day from respective labora-
tories.Mulenga et al. BMC Infectious Diseases 2010, 10:177
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Fingerprint analysis
Spoligotyping and MIRU-VNTR patterns were compared
to the international Spol DB4.0 database using MIRU-
VNTRplus, a freely available web-based program [20].
This allowed assignment of shared international spoligo-
type numbers (ST) to known profiles. Spoligotypes that
were not present in the Spol DB4.0 are referred to as
'orphan' types. MIRU-VNTR profiles with double alleles
at a single locus were considered to be clonal variants of
the same strain, whereas those with double alleles at 2 or
more loci were considered to be mixed infections [21,22].
Identical spoligotypes and MIRU-VNTR patterns were
considered to be in a cluster. Dendograms were generated
using the dice coefficient and the unweighted pair group
method with arithmetic averages (UPGMA). The cluster-
ing rate was defined as (nc- c)/n, where nc is the total
number of clustered cases, c is the number of clusters,
and n is the total number of cases in the sample. A cluster
was defined as two or more patterns with identical DNA
genotypes. The discriminatory power of DNA finger-
printing methods was calculated using the method
described by Hunter and Gaston [23].
Ethical Consideration
Before beginning the study, approval for the study proto-
col was obtained from the Ethics Committee at TDRC. In
addition, approval and support was also obtained from
the Director of the Ndola DHMT. The protocol was
implemented in such a way as to have minimum interfer-
ence with routine work at the clinics. The study did not
require any additional (invasive) sampling, data collected
was anonymized, there was no direct contact with the
patients, and the outcome of the research data would not
have an influence on patient management. As a result, we
did not ask informed consent from the subjects.
Statistical methods
Epidemiological and laboratory analysis data were double
entered and descriptive analyses done in Epi Info™ (Ver-
sion 3.2.2, Centers for Disease Control and Prevention,
Atlanta, GA, USA). All the electronic records were manu-
ally counterchecked against the source records for com-
pleteness and consistency.
The two sided Pearson's asymptotic and exact chi
square tests were appropriately used to assess associa-
tions of sex, age, geographic origin and drug-resistance
profiles with spoligotyping families or MIRU-VNTR clus-
ters using SAS® 9.2 (SAS Institute Inc., Cary, NC, USA.)
and StatXact® 4.0.1 (Cytel Software Corp., Cambridge,
MA, USA.). A P value less than 0.05 was considered sta-
tistically significant.
Figure 1 Distinct Spoligotypes of M. tuberculosis isolates from Ndo-
la. The dendogram was generated using the dice coefficient and the un-
weighted pair group method with arithmetic averages (UPGMA) using 
the MIRU-VNTRplus program [20].Mulenga et al. BMC Infectious Diseases 2010, 10:177
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Results
Subjects and isolates
A total of 361 sputum smear-positive PTB subjects from
the four selected diagnostic centres in Ndola were
enrolled into the study from January to July 2006. Isolates
were successfully obtained for 273 subjects, representing
54.7% (273/499) of all smear-positive PTB patients
recorded in Ndola district during this period. Samples for
the remaining 88 subjects included in the study, yielded
either contaminated (n = 10) or negative (n = 78) cul-
tures.
Of the cultures from 273 different subjects available for
DNA fingerprinting, 85 (31.1%) were female and 188
(68.9%) were male with an age range between 14 and 79
years and a median age of 31 years. All the isolates were
confirmed to be M. tuberculosis with an overall low drug
resistance level (unpublished data).
Characterization of M. tuberculosis lineages
We used spoligotyping to determine lineages of circulat-
ing M. tuberculosis strains in Ndola. A total of 98 differ-
ent spoligotypes were obtained among the 273 isolates
analyzed. Patterns from 177 isolates belonged to nine
families in the Spol DB4.0, whereas 96 (35.2%) isolates
could not be matched to any lineage, and are thus
referred to as 'orphan'.
The largest spoligotype family was the Latin American
Mediterranean (LAM) that accounted for 41.8% (114 iso-
lates) of the total isolates, most (100 isolates) of which
belonged to the LAM11_ZWE sub-family designated
Southern Africa Family 1 (SAF1) [24]. The next most
common family was the T family with 37 isolates (13.6%),
followed by the X family at 5.9% (16 isolates). A few iso-
lates (3.6%) belonged to the CAS, EAI, H, S, X1-LAM9 or
U families (Figure 1). Although our 'orphan' isolates were
not described in the Spol DB4.0, six of them showed spo-
ligotypes identical to previously reported orphan isolates
in Zambia (n = 2), Zimbabwe (n = 2) and Cape Town (n =
1) [24]. There was a uniform distribution of spoligotypes
from the various study centers (data not shown). Further,
no significant statistical differences were observed in the
distribution with regards to age (p = 0.5073), sex (p =
0.0896) and treatment history (p = 0.1824) between the
group for whom we were able to perform spoligotyping
and the group for which we could not.
Transmission analysis
To gain insight into the transmission rate of M. tuberculo-
sis in Ndola, 156 (57.1%) out of the 273 samples with spo-
ligotyping results were randomly selected and typed by
15-locus MIRU-VNTR.
MIRU-VNTR analysis revealed five isolates with clonal
subpopulations, i.e. the presence of double alleles at a sin-
gle locus suggestive of possible ongoing evolution within
a strain, and five mixed infection cases (3.2%) i.e. isolates
with double alleles at 2 to 5 MIRU-VNTR loci among the
156 isolates with MIRU-VNTR results. The mixed infec-
tion cases were removed from the analysis whereas the
isolates with clonal subpopulations were included in the
analysis with the double alleles at a single locus treated as
missing data. Thus, further analysis was performed on
the 151 isolates (Figure 2).
Not surprisingly, spoligotyping alone had the lowest
ability to differentiate the isolates in our sample (cluster-
ing rate of 74.2%) and a discriminatory power of 0.840.
MIRU-VNTR alone yielded a clustering rate of 39.1% and
a discriminatory power of 0.988. The highest discrimina-
tion was achieved when spoligotyping and MIRU-VNTR
were used together (h = 0.989; clustering rate of 37.7%),
which was marginally better than that of MIRU-VNTR
alone (Table 1 and Figure 2).
MIRU-VNTR typing of SAF1 isolates
We also assessed the genotypic similarity of isolates
belonging to the major spoligotype family SAF1 among
the above 151 isolates by 15-locus MIRU-VNTR. Of the
82 SAF1 isolates evaluated, MIRU-VNTR split the family
into 46 different patterns i.e. 13 clusters comprising 49
isolates and 33 unique patterns (Figure 3). All isolates that
were different by spoligotyping were also different by
MIRU-VNTR. The differentiation of SAF1 isolates in
clusters was mostly limited to one or two loci.
We did not observe any significant differences between
the group of patients for whom we performed MIRU-
VNTR and those we did not with regards to age (p =
0.8884), sex (p = 0.7350) and treatment history (p =
0.1536).
Discussion
This study reports the first utilization of spoligotyping
and MIRU-VNTR typing to study the diversity of M.
tuberculosis  isolates in Ndola using a large number of
samples. Ndola is an urbanized city with a high preva-
lence of HIV (17%) and is representative of many urban
towns along the line of rail in Zambia. Our results dem-
onstrate that the SAF1 family, and to a lesser extent the T
family are the main circulating TB genotypes in Ndola,
causing half (50.2%) of the TB cases in the city. The pre-
dominance of ST59 and ST53 of the SAF1 has been
shown to be ubiquitous in the southern African region
[24,25]. The small group of genotypes accounting for
most TB cases in Ndola may imply their long-standing
presence in the area. The clonal variations we saw for the
SAF1 family appear to support this notion.
The 15-locus MIRU-VNTR in our sample performed
very well. Although the comparison with IS6110-RFLP
was not available, the high discriminatory value achieved
by MIRU-VNTR in this study suggests that the techniqueMulenga et al. BMC Infectious Diseases 2010, 10:177
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Figure 2 Spoligotyping and MIRU-VNTR clustering of representative M. tuberculosis isolates from Ndola. The dendogram generated using the 
dice coefficient and the unweighted pair group method with arithmetic averages (UPGMA) using the MIRU-VNTRplus program [20]. ND: Not determ-
emined.Mulenga et al. BMC Infectious Diseases 2010, 10:177
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is suitable for studying the molecular epidemiology of TB
in Ndola. The high clustering rate (37.7%) exhibited in
this study suggests likely high transmission in the com-
munity that may have occurred both before and during
our study period since the study included both new and
retreatment cases. We did not find any evidence of labo-
ratory cross-contamination as a possible explanation for
the high cluster rate. Also, we did not observe any signifi-
cant differences between age, sex and treatment history
among analyzed and non-analyzed cases by either of the
typing techniques. The potential association of specific
genotypes or clusters with the HIV status of the patients
could not be investigated because HIV data was not rou-
tinely captured by the clinics format during the time of
study. Conventional epidemiological investigations of
contacts could not be performed due to budgetary con-
straints.
Our relatively short time window of sampling (7
months) is probably still acceptable to interpret the
observed clustering as resulting from 'recent transmis-
sion' [26] and might not be surprising in a high TB and
HIV incidence setting. Studies on clustering rates for
other African countries are rare and diverse both in
methodology and results; only a few of them have used
highly discriminatory typing techniques. In Botswana,
25% of investigated isolates from four communities (18
months sampling) clustered by IS6110-RFLP [27]
whereas a population-based nationwide study with a 21
months sampling period showed a 38% cluster rate [28].
Clustering was not associated with HIV or demographic
characteristics in both studies except for prior imprison-
ment in the first study. In Ethiopia, 41.2% of 121 isolates
(12 months sampling) clustered by IS6110  and a clear
association with HIV infection and female sex was
observed [29]. In Benin, 34% of isolates (15 months sam-
pling) clustered by 12-loci MIRU-VNTR and spoligotyp-
ing, with no parameters linked to clustering [30]. These
and our cluster rates are higher than the estimated 9-13%
of TB cases due to recent transmission in Malawi, where
nearly half of the cases acquired TB from an HIV-positive
subject [31].
Given the relatively short time window of our study
compared to other African studies, our clustering rate
should be considered high, and probably reflects a high
recent transmission rate emphasizing the importance of
early diagnosis and timely treatment. Further investiga-
tion on the link with HIV infection is required. We
acknowledge that the interpretation of transmission
dynamics data in this study may be limited because we
did not include smear negative subjects, who are known
to contribute to TB transmission [32-34].
On the one hand, these findings lend support to the
premise that M. tuberculosis in endemic areas with pre-
dominant family strains can still possess sufficient genetic
diversity when the appropriate molecular method is
applied, enabling more detailed epidemiologic investiga-
tions. On the other hand, since differentiation of SAF1
isolates by 15-locus MIRU-VNTR was mostly limited to
one or two loci, application of the standardized 24-locus
MIRU-VNTR [35] - not used in this study due to financial
constraints - may increase the ability to discriminate
more MTBC among the clustered SAF1 strains.
This study also detected mixed infections in five sub-
jects. Except for 1 of these 5 subjects, who exhibited INH
resistance, isolates from the other 4 subjects, were pan-
susceptible to the anti-TB drugs tested. The rate of mixed
infections detected in this study (at least 3.1% observed
among 156 isolates with MIRU-VNTR results) is compa-
rable to previous reports from high-incidence popula-
tions [21,22,36-38]. Although this observation does not
necessarily pose a serious threat for patient management
owing to the relatively low level of drug resistance in this
setting, it is potentially an important factor to consider
particularly for treatment of compliant subjects with
unexplained changes in drug resistance patterns during
the course of chemotherapy.
Conclusion
This study has shown that the majority of MTBC isolates
in Ndola belongs to the SAF1 family with a high cluster-
ing rate and that the 15-locus MIRU-VNTR typing is
suitable for studying the molecular epidemiology of TB in
Table 1: Discriminatory power of spoligotyping and 15-locus MIRU-VNTR among 151 M. tuberculosis isolates from Ndola, 
Zambia
Genotyping 
method
Number of 
different 
profiles
Number of 
isolates with 
unique 
profile
Number of 
clusters
Number of 
isolates in 
clusters
Clustering 
rate (%)
h index
Spoligotyping 39 27 12 124 74.2 0.840
M I R U - V N T R 9 26 52 78 6 3 9 . 1 0 . 9 8 8
MIRU-VNTR + 
spoligotyping
94 68 26 83 37.7 0.989Mulenga et al. BMC Infectious Diseases 2010, 10:177
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Figure 3 MIRU-VNTR clustering of M. tuberculosis isolates belonging to the SAF1 family. The dendogram was generated using the dice coeffi-
cient and the unweighted pair group method with arithmetic averages (UPGMA) using the MIRU-VNTRplus program [20].Mulenga et al. BMC Infectious Diseases 2010, 10:177
http://www.biomedcentral.com/1471-2334/10/177
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Ndola. Finally, the probable high recent transmission rate
underlines the importance of early diagnosis and timely
treatment.
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